KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Capital Employed (2016 - 2025)

Neogenomics (NEO) has disclosed Return on Capital Employed for 15 consecutive years, with 0.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2025, up 1.0%, and an annual FY2025 reading of 0.08%, down 1.0% over the prior year.
  • Return on Capital Employed was 0.06% for Q4 2025 at Neogenomics, up from 0.06% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.02% in Q2 2021 and bottomed at 0.1% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.07%, with a median of 0.07% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -8bps in 2022, then rose 3bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.07% in 2021, then plummeted by -44bps to 0.1% in 2022, then grew by 28bps to 0.07% in 2023, then dropped by -1bps to 0.07% in 2024, then rose by 15bps to 0.06% in 2025.
  • Business Quant data shows Return on Capital Employed for NEO at 0.06% in Q4 2025, 0.06% in Q3 2025, and 0.08% in Q2 2025.